Related Experiment Video

Updated: Jul 17, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

[Mechanisms responsible for antitumor activity of melanoma differentiation-associated gene -7/interleukin-24]

Min Yang1, Wen-Bin Qian

  • 1The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|February 10, 2007
PubMed

Insights

Melanoma differentiation-associated gene-7/interleukin-24 (MDA-7/IL-24) shows promise as a tumor suppressor. This gene inhibits cancer cell proliferation and induces apoptosis in malignant cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Context:

  • The melanoma differentiation-associated gene-7/interleukin-24 (MDA-7/IL-24) is recognized for its potential anti-cancer properties.
  • Understanding the mechanisms of novel tumor suppressors is crucial for developing new cancer therapies.

Purpose:

  • To investigate the role of MDA-7/IL-24 as a tumor suppressor.
  • To evaluate the experimental effects of MDA-7/IL-24 on cancer cell proliferation and apoptosis.

Summary:

  • MDA-7/IL-24 demonstrates significant potential as a tumor suppressor.
  • Experimental evidence shows that MDA-7/IL-24 can inhibit the proliferation of various cancer cells.
  • MDA-7/IL-24 has been shown to induce apoptosis (programmed cell death) in multiple human malignant cell types.

Impact:

  • Highlights MDA-7/IL-24 as a potential therapeutic agent for cancer treatment.
  • Provides a foundation for further research into gene therapy strategies targeting cancer.
  • Suggests MDA-7/IL-24 could be a key player in future oncology interventions.

More Related Videos

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.